Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation

Abstract

IntroductionHepatocellular carcinoma (HCC) is the most prevalent primary liver cancer kind. According to recent research, a fatty liver increases the risk of hepatocellular cancer. Nevertheless, the AMPK signaling pathway is crucial. In addition, 5’-AMP-activated protein kinase (AMPK) is strongly linked to alterations in the tumor microenvironment, such as inflammation, hypoxia, and aging. The objective of this study is to evaluate the impact of the AMPK signaling pathway on the progression of fatty liver to HCC.MethodsIn this study, we established a mouse liver cancer model using high-fat diets and nano-nitrosamines (nano-DEN). In addition, we employed a transcriptomic technique to identify all mRNAs detected in liver samples at the 25th weekexpression of proteins linked with the LKB1-AMPK-mTOR signaling pathway, inflammation, aging, and hypoxia was studied in microarrays of liver cancer tissues from mice and humans. These proteins included p-AMPK, LKB1, mTOR, COX-2, β-catenin, HMGB1, p16, and HIF-1α.ResultsData were collected at different times in the liver as well as in cancerous and paracancerous regions and analyzed by a multispectral imaging system. The results showed that most of the genes in the AMPK signaling pathway were downregulated. Prakk1 expression was upregulated compared to control group but downregulated in the cancerous regions compared to the paracancerous regions. Stk11 expression was downregulated in the cancerous regions. Mtor expression was upregulated in the cancerous regions. During liver cancer formation, deletion of LKB1 in the LKB1-AMPK-mTOR signaling pathway reduces phosphorylation of AMPK. It contributed to the upregulation of mTOR, which further led to the upregulation of HIF1α. In addition, the expression of β-catenin, COX-2, and HMGB1 were upregulated, as well as the expression of p16 was downregulated.DiscussionThese findings suggest that changes in the AMPK signaling pathway exacerbate the deterioration of disrupted energy metabolism, chronic inflammation, hypoxia, and cellular aging in the tumor microenvironment, promoting the development of fatty liver into liver cancer.

Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis

“…Our research has further revealed that Veillonellaceae , Alistipes , Enterobacteriales , and Firmicutes can promote the formation of ICC through the regulation of the AMPK signaling pathway and the mTOR signaling pathway. Meng et al (2023) have similarly reported that alterations in the AMPK- mTOR signaling pathway can exacerbate the progression of disrupted energy metabolism, chronic inflammation, hypoxia, and cellular aging within the tumor microenvironment. These factors collectively promote the transformation of fatty liver into liver cancer.…”

Natural products targeting macroautophagy signaling in hepatocellular carcinoma therapy: Recent evidence and perspectives

“…In the study of HCC, a recent study found that AMPK signaling pathway plays a crucial role in the transformation of fatty liver into HCC. Malignant changes in cell microenvironment inhibit AMPK signaling pathway and then cause a series of changes in cell processes, including metabolic disorders, cell senescence, and chronic inflammation of liver, which deepens the transformation of normal cells into cancer cells (Meng et al, 2023). An article published in Hepatology clearly indicates that metabolic differences between HCC cells and normal liver cells, especially in glutamine metabolism, contribute to the development of HCC tumors.…”